Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 85
Treatment-assignment count: 0
Stratification count: 1
breast cancer · Small Molecule Inhibitor
MET exon 14 skipping is flagged as manual review required because public trials show inclusion required evidence in 91 contexts. FDA CDx context should be reviewed manually. Threshold text varies across public records.
Strongest role: Inclusion Required
Inclusion-required count: 85
Treatment-assignment count: 0
Stratification count: 1
Threshold count: 5
Common snippets: HER2-low | EGFR exon 19 deletion | dMMR
Threshold label: Fragmented
CDx label: Fda Cdx Context Not Found
CDx maturity score: 1/5
Confidence: Low
Signal count: 0
Recent signals: 0
Density label: Low
https://clinicaltrials.gov/study/NCT00298675 | https://clinicaltrials.gov/study/NCT01684215 | https://clinicaltrials.gov/study/NCT04669587 | https://clinicaltrials.gov/study/NCT02474173 | https://clinicaltrials.gov/study/NCT01430585 | https://clinicaltrials.gov/study/NCT05082259 | https://clinicaltrials.gov/study/NCT02326844 | https://clinicaltrials.gov/study/NCT01743560 | https://clinicaltrials.gov/study/NCT02619669 | https://clinicaltrials.gov/study/NCT01915576 | https://clinicaltrials.gov/study/NCT01989546 | https://clinicaltrials.gov/study/NCT05252416 | https://clinicaltrials.gov/study/NCT01476137 | https://clinicaltrials.gov/study/NCT04090567 | https://clinicaltrials.gov/study/NCT00075270 | https://clinicaltrials.gov/study/NCT03562832 | https://clinicaltrials.gov/study/NCT03654547 | https://clinicaltrials.gov/study/NCT01705340 | https://clinicaltrials.gov/study/NCT01513356 | https://clinicaltrials.gov/study/NCT05422794 | https://clinicaltrials.gov/study/NCT05732428 | https://clinicaltrials.gov/study/NCT06799065 | https://clinicaltrials.gov/study/NCT00070252 | https://clinicaltrials.gov/study/NCT02340221 | https://clinicaltrials.gov/study/NCT04001569 | https://clinicaltrials.gov/study/NCT01151449 | https://clinicaltrials.gov/study/NCT02569801 | https://clinicaltrials.gov/study/NCT04318223 | https://clinicaltrials.gov/study/NCT02544997 | https://clinicaltrials.gov/study/NCT02163694 | https://clinicaltrials.gov/study/NCT06618287 | https://clinicaltrials.gov/study/NCT01556191 | https://clinicaltrials.gov/study/NCT07174336 | https://clinicaltrials.gov/study/NCT04576455 | https://clinicaltrials.gov/study/NCT02401347 | https://clinicaltrials.gov/study/NCT06656624 | https://clinicaltrials.gov/study/NCT00051051 | https://clinicaltrials.gov/study/NCT03306472 | https://clinicaltrials.gov/study/NCT01589861 | https://clinicaltrials.gov/study/NCT04568616 | https://clinicaltrials.gov/study/NCT01071564 | https://clinicaltrials.gov/study/NCT03913234 | https://clinicaltrials.gov/study/NCT06107673 | https://clinicaltrials.gov/study/NCT05749575 | https://clinicaltrials.gov/study/NCT05295043 | https://clinicaltrials.gov/study/NCT02802748 | https://clinicaltrials.gov/study/NCT01158274 | https://clinicaltrials.gov/study/NCT05766410 | https://clinicaltrials.gov/study/NCT06176534 | https://clinicaltrials.gov/study/NCT04684459 | https://clinicaltrials.gov/study/NCT02187991 | https://clinicaltrials.gov/study/NCT00633750 | https://clinicaltrials.gov/study/NCT01194908 | https://clinicaltrials.gov/study/NCT03952325 | https://clinicaltrials.gov/study/NCT02863900 | https://clinicaltrials.gov/study/NCT05378204 | https://clinicaltrials.gov/study/NCT01928186 | https://clinicaltrials.gov/study/NCT07401537 | https://clinicaltrials.gov/study/NCT06810492 | https://clinicaltrials.gov/study/NCT01301911 | https://clinicaltrials.gov/study/NCT01013506 | https://clinicaltrials.gov/study/NCT05429684 | https://clinicaltrials.gov/study/NCT01245205 | https://clinicaltrials.gov/study/NCT06471673 | https://clinicaltrials.gov/study/NCT05069038 | https://clinicaltrials.gov/study/NCT00674557 | https://clinicaltrials.gov/study/NCT03168880 | https://clinicaltrials.gov/study/NCT06133088 | https://clinicaltrials.gov/study/NCT05594095 | https://clinicaltrials.gov/study/NCT05183828 | https://clinicaltrials.gov/study/NCT01732276 | https://clinicaltrials.gov/study/NCT01208441 | https://clinicaltrials.gov/study/NCT05163106 | https://clinicaltrials.gov/study/NCT03523572 | https://clinicaltrials.gov/study/NCT04551495 | https://clinicaltrials.gov/study/NCT07162259 | https://clinicaltrials.gov/study/NCT02499146 | https://clinicaltrials.gov/study/NCT05861830 | https://clinicaltrials.gov/study/NCT07327021 | https://clinicaltrials.gov/study/NCT01723774 | https://clinicaltrials.gov/study/NCT02685059 | https://clinicaltrials.gov/study/NCT03911453 | https://clinicaltrials.gov/study/NCT06022029 | https://clinicaltrials.gov/study/NCT05429866 | https://clinicaltrials.gov/study/NCT06625515 | https://clinicaltrials.gov/study/NCT03775850 | https://clinicaltrials.gov/study/NCT06671912 | https://clinicaltrials.gov/study/NCT04034589 | https://clinicaltrials.gov/study/NCT06328387 | https://clinicaltrials.gov/study/NCT03894007 | https://clinicaltrials.gov/study/NCT04759248